Safeguard Scientifics reports $60.8M cash proceeds from 2021 exits; initiates strategic review

SAFEGUARD SCIENTIFICS INC

Repurchased 4.5M shares in 2021, including 4.3M via Dutch auction at $9.06 per share.
Received $44.8M from Flashtalking exit, $32.5M gain; $3.5M cash + $15.3M preferred equity from Zipnosis.
BHG IPO converted preferred to 1.3M common shares; fair value fell to $4.5M by year-end.
Deployments totaled $2.7M in 2021; funded $2M convertible loan to Prognos Health post-year-end.
Board initiated evaluation of strategic alternatives to enhance shareholder value.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.